Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania. by Cox, Sharon E et al.
Cox, SE; Makani, J; Fulford, AJ; Komba, AN; Soka, D; Williams, TN;
Newton, CR; Marsh, K; Prentice, AM (2011) Nutritional status, hos-
pitalization and mortality among patients with sickle cell anemia in
Tanzania. Haematologica, 96 (7). pp. 948-53. ISSN 0390-6078
Downloaded from: http://researchonline.lshtm.ac.uk/431/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial
http://creativecommons.org/licenses/by-nc/2.5/
948
ORIGINAL ARTICLES
Acknowledgments: we warmly
thank the patients and staff 
of MNH and MUHAS, Dar-es-
Salaam, Tanzania who made 
this work possible. We also 
thank Josephine Mgaya and
Harvest Mariki for the sickle
diagnoses and work in generat-
ing the laboratory data, and
Fenella Kirkham for commenting
on the manuscript. 
Funding: we thank the Wellcome
Trust for funding this research:
(SC) project grant 080025;
(JM) 072064; strategic award
084538 and the Kenya Medical
Research Institute (KEMRI) -
Centre for Geographic Medicine
Research (Coast).
Manuscript received on
May 24, 2010. Revised
version arrived on March 28,
2011. Manuscript accepted 
on March 30, 2011.
Correspondence: 
Sharon Cox, Department
of Haematology and Blood
Transfusion, Muhimbili University
of Health and Allied Sciences, 
PO Box 65001, Dar-es-Salaam,
Tanzania.
E-mail: sharon.cox@lshtm.ac.uk 
Background
Reduced growth is common in children with sickle cell anemia, but few data exist on associa-
tions with long-term clinical course. Our objective was to determine the prevalence of malnu-
trition at enrolment into a hospital-based cohort and whether poor nutritional status predicted
morbidity and mortality within an urban cohort of Tanzanian sickle cell anemia patients. 
Design and Methods
Anthropometry was conducted at enrolment into the sickle cell anemia cohort (n=1,618; ages
0.5-48 years) and in controls who attended screening (siblings, walk-ins and referrals) but who
were found not to have sickle cell anemia (n=717; ages 0.5-64 years). Prospective surveillance
recorded hospitalization at Muhimbili National Hospital and mortality between March 2004
and September 2009. 
Results
Sickle cell anemia was associated with stunting (OR=1.92, P<0.001, 36.2%) and wasting
(OR=1.66, P=0.002, 18.4%). The greatest growth deficits were observed in adolescents and in
boys. Independent of age and sex, lower hemoglobin concentration was associated with
increased odds of malnutrition in sickle cell patients.  Of the 1,041 sickle cell anemia patients
with a body mass index z-score at enrolment, 92% were followed up until September 2009
(n=908) or death (n=50). Body mass index and weight-for-age z-score predicted hospitalization
(hazard ratio [HZR]=0.90, P=0.04 and HZR=0.88, P=0.02) but height-for-age z-score did not
(HZR=0.93, NS).  The mortality rate of 2.5 per 100 person-years was not associated with any
of the anthropometric measures.
Conclusions
In this non-birth-cohort of sickle cell anemia with significant associated undernutrition, wast-
ing predicted an increased risk of hospital admission. Targeted nutritional interventions should
prioritize treatment and prevention of wasting.
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Introduction
Sickle cell anemia (SCA) is one of the most common sin-
gle gene disorders in the world, designated by the World
Health Organization as a public health priority.1
Knowledge of the natural history and improved manage-
ment of SCA has been gained from systematic studies,
largely in the USA and Jamaica. However, SCA is predom-
inantly an African disease, with the majority of affected
births (homozygous inheritance of hemoglobin S–[HbSS])
occurring in Africa.2 Although SCA is a single gene disor-
der, the clinical expression and severity of the disease are
surprisingly varied, and are thought to result from epistatic
interactions from other genes and/or environmental fac-
tors.3
Energy and nutrient supplies are likely to be limited or
compromised in SCA by a combination of factors: (i)
reduced intake4 potentially from the anorexic effects of co-
morbidities;5 (ii) decreased absorption of nutrients; (iii)
increased degradation and losses of nutrients;6 increased
requirements from an elevated basal metabolic rate;7 and
alterations in metabolic pathways.8,9 Poor growth has
been previously documented in SCA.10-12 However, the
causes and clinical significance are not well understood.13
In Africa, where dietary intakes are sub-optimal for
many populations, we hypothesized that nutrition is an
important modifiable risk factor for SCA morbidity and
that poor nutritional status is associated with increased
mortality and morbidity. Here we describe anthropomet-
ric measures of nutritional status in a large cohort of
Tanzanian SCA patients at enrolment. Factors associated
with poor nutritional status and its consequences on mor-
tality and morbidity are analyzed.
Design and Methods
Ethics statement
The study received ethical approval from Muhimbili University
of Health and Allied Sciences reference MU/RP/AEC/VOL XI/33)
and the London School of Hygiene and Tropical Medicine (refer-
ence 5158).
Patients and clinical procedures
Screening is not currently available for the newborn in
Tanzania. Patients were recruited from the SCA clinic at
Muhimbili National Hospital, the national referral hospital in Dar-
es-Salaam, Tanzania, for five years from March 2004. Informed
consent was obtained from patients or guardians at screening and
at enrolment into the cohort. Anthropometric status of SCA
patients at enrolment was compared to individuals screened for
SCA but found to be either HbAA or HbAS during this recruit-
ment period. All SCA patients are seen at scheduled routine visits
(every 3-6 months) at the Muhimbili National Hospital SCA clinic
and receive daily folate supplementation (5 mg/day) and anti-
malarial prophylaxis according to Tanzanian government guide-
lines. Those subjects with SCA receive free public health care.
Those with acute illness were referred from district health facili-
ties or came directly to Muhimbili National Hospital emergency
department and were managed or hospitalized according to hos-
pital protocols.
Procedures at enrolment
Out of 1,982 screened patients with HbSS, 1,748 (88%) returned
for enrolment and were issued with a unique identity number.
Physical examinations were performed and detailed histories were
recorded, including history of dactlytis (painful inflammation of
fingers or toes) and number of previous hospital admissions. Blood
samples were collected for full blood counts (FBC), detection of
malaria plus confirmation of HbSS status and fetal hemoglobin
(HbF) fraction by high performance liquid chromatography
(HPLC) and, for a period of time, a clinical chemistry panel were
all carried out. 
Procedures for detection of inpatient admissions 
to MNH, death and loss to follow up
SCA patients hospitalized at Muhimbili National Hospital
were identified through daily ward surveillance. The decision to
admit SCA patients was the responsibility of the attending clini-
cian in the hospital casualty department, according to criteria of
hospital protocols.  SCA patients who did not attend scheduled
clinic visits for 6-12 months or more were traced by telephone or
home visits. SCA patients were followed up until September 2009. 
Anthropometry
Height (nearest cm), weight (nearest 0.1 kg) were measured
using standardized techniques. Z-scores for height-for-age (HAZ),
weight-for-age (WAZ), and body-mass-index for age (BMIZ) were
calculated for patients aged over 60 months against the UK1990
reference values using the zanthro programme14 (STATA 9;
StataCorp, College Station, TX, USA). For children aged under 60
months, WHO 2006/2007 reference values15 were used using
igrowup-stata (http://www.who.int/childgrowth/en/). Levels of malnu-
trition (stunting, underweight and wasting) were defined as Z-
scores of less than -2 but more than -3 for moderate and less than
-3 for severe. HAZ scores determined the severity of stunting,
WAZ, underweight and BMIZ, wasting. Nutritional status centiles
were plotted and internal z-scores for SCA generated using LMS
chartmaker-Pro-v.2.3 (Tim Cole and Huiqi Pan. Copyright 1997-
2006, Medical Research Council, UK).
Laboratory procedures
At screening or after an appropriate interval for patients who
had recently had a blood transfusion, individuals were typed for
HbS by alkaline Hb electrophoresis (Helena, Sunderland, Tyne and
Wear, UK). At enrolment, hemoglobin fractions, including HbF,
were quantified by HPLC using the β-thalassemia Short
Programme on the Variant analyser (BioRad, Hercules, CA, USA)
confirming the previous diagnosis.  Full blood counts (FBC) were
performed using an automated cell counter (Pentra 60, Horiba
ABX, Kyoto, Japan). Biochemical tests were performed using an
automated chemistry analyzer (Abbott Architect, NY, USA). 
Statistical analysis
Data were analyzed using STATA ICv9. Internal z-scores were
used to assess relative nutritional status within our SCA population
(ensuring a normal distribution) with risk of mortality and risk of in-
patient admission to Muhimbili National Hospital using Cox’s
regression with the Cnaan and Ryan approach, modeling the effect
of age at enrolment.16 Hospital admissions less than seven days
apart were treated as a single event and the previous number of
admissions was included as a co-factor when analyzing the risk of
subsequent admissions. Adjustment for clustering within families
(124 family groups [full or half siblings or mother/father child
groupings]) was performed and repeated events within individuals
accounted for using robust standard errors. The end date for obser-
vation was the date of last contact either at the clinic, through trac-
ing activities or during a hospital admission, or date of death.  
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Results
Height, weight, age, sex and a valid BMI were available
for 1,041 SCA cases at enrolment (49% males) and for
717 controls (HbAS or HbAA). Cases were significantly
younger than controls (mean 10.1 vs. 13.8 years, P<0.001).
Overall, sex distribution was similar with 49% male cases
vs. 48% in controls, but the proportion of males decreased
significantly with age in both groups (P=0.001). Mean
HbF% in SCA was 5.5 (SD=4.2; N=965 [>5y]) and mean
hemoglobin 7.5g/dl (SD=1.4) vs. 11.0g/dl (SD=2.6)
(P<0.001).  
Nutritional status in Tanzanian SCA 
Table 1 demonstrates a significantly increased preva-
lence of malnutrition (<-2 z-scores for HAZ, WAZ, and
BMIZ) in SCA versus non-SCA.  Centile plots displaying
Table 1. Prevalence of malnutrition in SCA compared to non-SCA.
SCA Non-SCA
Mod Sev Mod Sev SCA vs. non-SCA*
n (%) n (%) n (%) n (%) OR [95% CI]
Stunting HAZ-score 238 (23) 130 (13) 94 (17) 41 (7) 1.82 [1.43/2.32]
SCA (N=1024) non-SCA P<0.001
(N=562)
Underweight WAZ-score 240 (24) 115 (11) 84 (15) 44 (8) 2.61 [2.06/3.31]
SCA (N=1019) non-SCA P<0.001
(N=573)
Wasting BMIZ-score 105 (10) 55 (5) 59 (10) 18 (3) 1.66 [1.21/2.28]
SCA (N=1041) non-SCA P=0.002
(N=583)
Mod: moderate (<-2 z-score>-3 z-score); Sev = Severe (<-3 z-score). *Odds ratio of malnutrition
(moderate and severe combined), adjusted for age (in years) and sex. Logistic regression mod-
els were limited to those with a valid BMIZ-score; clustering within families was adjusted by cal-
culation of robust standard errors. 
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Figure 1. Height, weight and BMI centile plots for SCA compared to UK reference data.14 (A, C) and (E) are for females and (B, D) and (F) for
males. Red dotted lines are the 95th, median and 5th centile curves for UK reference data14 (1990); solid blue lines represent the 95th, median
and 5th centile curves for the Tanzanian SCA population. UK reference curves were extrapolated at the same level after the maximum age
available of 23 years.
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the 5th to 95th percentile ranges of height, weight and BMI
in SCA at enrolment by age and sex compared to UK ref-
erence data are shown in Figure 1. 
Stunting
The centile plots in Figure 1 demonstrate the greatest
deficits in height in SCA during adolescence, but also an
extended growth period and potential for catch-up
growth, more pronounced for females (Figure 1), resulting
in males being more likely to be stunted as adults (>18y,
OR=2.48 [1.19/5.17] P=0.015). 
Underweight
Adult males were seven times more likely to be under-
weight than females (OR=7.01 [3.21/15.50] P<0.001),
whilst in the 5-10 years age group, males were less likely
to be underweight (OR=0.52 [0.31/0.86] P=0.011).  Figure
1 clearly demonstrates low weight in adolescence, most
pronounced in males, and the large variation in weight for
females.
Wasting
Wasting was most prevalent in adolescents and adults.
However, the mean BMI in adults was 20.0 kg/m2 (95%CI
19.5–20.5) and was thus considered to be within the
healthy range (17.5-25 kg/m2). Similar to underweight sta-
tus, adult males had an increased risk of wasting
(OR=4.15 [1.95/8.82] P<0.001) but males aged 5-10 years
had a significantly decreased risk (OR=0.50 [0.25/0.99]
P=0.048). 
Factors associated with increased odds of malnutrition
at enrolment
When sex and age were included in multivariable mod-
els a priori, there was no effect of HbF%, generally
reported to be a strong modulator of SCA disease severi-
ty, and associated with age and sex.17 In multivariable
models, the only significant variables were age, history of
dactylitis, unconjugated bilirubin and Hb concentrations
(Table 2). 
Hemolysis, anemia and malnutrition in SCA
Unconjugated bilirubin and lactate dehydrogenase are
considered markers of hemolysis and are reported to be
associated with disease severity.18 Raised levels of these
markers were significantly associated with decreased
hemoglobin concentrations (data not shown). However,
none were significantly associated with nutritional status
when age and sex (but not hemoglobin) were included in
models, except for a positive association between uncon-
jugated bilirubin concentrations and odds of wasting
(P=0.037).
Nutritional status at enrolment and risk of mortality 
Internal z-scores were used to assess how relative nutri-
tional status of individuals was associated with mortality.
Of the 1,041 SCA patients with a BMI z-score at enrol-
ment, 958 (92%) were followed up until September 2009
or until death (n=50). Median follow up was 2.1 (range
0.02-5.4) years. The incidence rate of death was 2.5 per
100 person years observation (PYO) (95%CI 1.9-3.3), sim-
ilar to the full cohort at 2.0 per 100 PYO.19 Controlling for
age at enrolment, and stratified by age group, there was
no evidence of an association between nutritional status
at enrolment and risk of mortality, for example: BMI-
internal z-score (BMIiZ score) hazard ratio [HZR]=1.02
[95% CI 0.76-1.37; P=0.91] and no difference according to
sex. However, as for the whole cohort,19 hemoglobin con-
centrations were significantly negatively associated with
mortality, with a 30% decrease in risk per g/dl increase in
hemoglobin (HZR=0.69, [95% CI 0.56-0.85], P=0.001)
when limited to this population with anthropometric
data.  
Nutritional status at enrolment and risk 
of hospitalization
Of the 1,041 with BMIZ scores at enrolment, 985
returned for at least one routine follow-up visit and were
included in this analysis. There were 419 admissions in
385 (36%) subjects; 238 of these contributing one event
only (maximum number of events per person was 11) and
a total of 2,378 PYO. There were 17.6 (95%CI 16.0-19.4)
Nutritional status in sickle cell anemia
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Table 2. Multivariable models of factors associated with malnutrition in SCA at enrolment into the cohort.
Stunting Underweight Wasting
(<-2 HAZ-score) (<-2 WAZ-score) (<-2 BMIZ-score)
OR [95% CI] P value OR [95% CI] P value OR [95% CI] P value
Age in years 1.02 [1.00/1.04] 0.033 1.05 [1.03/1.07] <0.001 1.06 [1.04/1.09] <0.001
Hb [g/dL] 0.80 [0.72/0.89] <0.001 0.86 [0.78/0.96] 0.005 0.96 [0.82/1.12] 0.62
Dactylitis in previous year 1.90 [1.31/2.76] 0.001 - - - -
Unconjugated bilirubin - - - - 1.005 [1.0008/1.008] 0.017
Logistic regression models were limited to those with a valid BMIZ-score; clustering within families was adjusted for by calculation of robust standard errors. Age and sex were
included in models a priori.  
Table 3. Relative nutritional status within SCA and risk of hospital
admission.
Risk of hospitalization
Univariable models Events/N Hazard ratio P value
[95% CI]
HAiZ-score 415/975 0.91 [0.82/0.99] 0.048
WAiZ-score 415/975 0.87 [0.78/0.97] 0.009
BMIiZ-score 419/985 0.90 [0.82/0.99] 0.042
Hb [g/dL] 393/879 0.93 [0.87/0.99] 0.037
Multivariable model stunting
HAiZ-score 393/879 0.93 [0.84/1.03] 0.16
Hb [g/dL] 0.95 [0.88/1.01] 0.094
Multivariable model underweight
WAiZ-score 389/869 0.88 [0.79/0.98] 0.017
Hb [g/dL] 0.95 [0.98/1.02] 0.14
Multivariable model wasting
BMIiZ-score 393/879 0.90 [0.82/0.99] 0.043
Hb [g/dL] 0.94 [0.88/0.99] 0.046
Cox’s regression models are controlled for age at enrolment, sex and previous number
of hospital admissions. 
admissions per 100 PYO. Independent of age at enrol-
ment, poorer nutritional status was significantly associat-
ed with increased risk of hospitalization (Table 3), with
the greatest effect size for relative weight-for-age (greater
WAiZ score, HZR=0.87, P=0.009), equivalent to a 13%
reduction in risk for each increase in WAiZ score of one
SD. Baseline hemoglobin concentration was also nega-
tively associated (HZR=0.93 per 0.1g/dl, P=0.037).
Baseline hemoglobin and BMIiZ score were independent-
ly associated with risk of admission (Table 3). Sex had no
effect on hospitalization (HZR=0.95, P=0.50).  
Discussion
Prevalence of malnutrition in SCA by age and sex
This is one of the largest analyses of nutritional status of
SCA patients at a single site, and certainly within Africa.
Our data suggest a similar or lower prevalence of malnu-
trition in SCA compared to other African studies.20-22
Unsurprisingly, compared to patients enrolled in compre-
hensive care programs in the USA23,24 or the UK,25
Tanzanian SCA patients experience a greater prevalence
of malnutrition compared to local controls. For example,
in 178 American SCA children (0-18 years), the propor-
tion who were ever less than the US National Center
Health Statistics (NCHS) 5th percentile for height, weight
or BMI during four years of follow up was 22-26%,12
compared to 36-38% less than the 2.5th percentile (<-2
SD) for height and weight in our cohort at baseline.
However, only 18% of our cohort were less than the 2.5th
percentile for BMI, suggesting adaptation to chronic ener-
gy/nutrient deficiency, perhaps from slowed rates of
growth and stunting. Alternatively, it may represent a sur-
vivor cohort effect.  
Differences in nutritional status according to sex within
SCA have been reported previously. In most cases, similar
to our study, nutritional status was worse in males com-
pared to females11,26-28 although one study reported the
contrary.29 However, in the one study that assessed dis-
ease severity in relation to growth, effect was limited to
females.12 Disparity between the age groups in these stud-
ies and differences in effects of SCA on pubertal delay
between males and females may underlie these discrep-
ancies.  We observed that the most growth retardation
was experienced in adolescents. This is likely, at least in
part, an artifact from delayed and extended puberty, par-
ticularly in females which allows for a substantial degree
of catch-up growth. This has already been seen in
Jamaican patients, for whom longitudinal centile growth
curves were plotted and reference data generated.11 The
reasons why females should experience more catch-up
growth than males is not clear. 
Clinical impact of nutritional status in SCA
We believe that this is the first report that has attempt-
ed to assess the relationship between nutritional status
and mortality within SCA. In the UK East London
Cohort with a very high rate of survival,25 malnutrition is
uncommon with only 6.5% of 2-15 year olds having a z-
score of less than -2 for weight-for-age and 4.2% for
height-for-age or BMI13 suggesting that improved nutri-
tional status may have increased survival or that
increased care has resulted in milder disease and
improved nutritional status. Supporting the latter possi-
bility, hydroxyurea therapy has been associated with a
decrease in resting energy expenditure, correlated with
increased HbF expression, and decreased wasting.5 The
lack of an association between nutritional status and
mortality in our cohort is, therefore, surprising. There is
strong evidence to show that poor nutritional status is a
contributory factor for mortality in children in general.30-
32 Furthermore, we observed strong associations between
hemoglobin and nutritional status and between hemo-
globin and mortality; in addition poor nutritional status
at enrolment was associated with risk of hospitalization,
expected to be a good indicator of disease severity. It is
possible that an effect of malnutrition on mortality in our
SCA population is limited to young children who have
the highest mortality among SCA patients, due particu-
larly to infections,25,33-35 including in our cohort.19
Malnutrition may have the greatest effect on mortality
when mediated through an interaction with infections,
as suggested in a Kenyan study in which the majority of
deaths in young children attributable to malnutrition
were ascribed to infection as the immediate cause of
death.36 In the absence of newborn screening, this survivor
cohort, with a small number of patients in the youngest,
most vulnerable age group, may have resulted in a lack of
power to detect a true association. Reduced growth may
also be an adaptation to a chronic undersupply of energy
and nutrients, reducing total energy requirements, and
allowing available energy and nutrients to be directed
towards maintaining essential metabolic defenses against
disease processes. Smaller body size will also ameliorate
the effects of chronic anemia on cardiac load. The lower
prevalence of wasting compared to stunting and under-
weight may support this hypothesis. Good nutritional
status was not found to predict a benign clinical course in
Jamaican SCA patients, also indicating an element of pro-
tective adaptation.37 Finally, although wasting and under-
weight were risk factors for hospitalization, stunting was
not. Therefore, wasting may represent a failure of the
adaptive processes or alternatively be precipitated by
events that lead to the hospital admission. Unfortunately,
the cause of death remains unknown for the majority of
cases in our cohort, due to the high number of deaths
that occurred in the home.19
Conclusions
In our urban setting, sickle cell anemia is associated
with a high prevalence of malnutrition and growth retar-
dation in patients of all ages, but particularly in adoles-
cents. Contrary to expectations, there was no evidence of
an association between malnutrition and mortality during
the 5.5 year period of follow up, although there was an
association with symptomatic disease as captured by data
regarding hospitalization. A birth cohort and analysis of
growth rates with hospitalization and other indicators of
disease severity in different age groups is required to
determine relationships between malnutrition and SCA
disease outcome.
The relationships between hemoglobin concentration,
nutritional status and severity of disease, and the poten-
tial effects and extent of delayed pubertal development
warrant further longitudinal investigation. Nutritional
interventions may play an important role in enhancing
healthy survival rates in SCA patients, but need to be
appropriately tested before widespread implementation
can be recommended.
S.E Cox et al.
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